Reducing Opioid Use and Misuse After Wisdom Molar Extractions

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

133

Participants

Timeline

Start Date

November 30, 2024

Primary Completion Date

November 30, 2026

Study Completion Date

April 30, 2027

Conditions
Pain, Postoperative
Interventions
DRUG

Twin block

Dental local anesthetic administered to target the jaw 'closer' muscles, temporalis and masseter

DEVICE

iPill dispenser

An active pill dispenser, regulated by patient's pain score entered on an iPill App installed on their smart phone (iPhone, Android) to dispense opioid (for pain corresponding to severe pain) or prescription strength ibuprofen and acetaminophen (for moderate pain), with over the counter solutions for mild pain recommended. This pill dispenser will be given to all patients, in both Twin block and Control groups, to regulate and monitor their pain experience-driven pain medication regimen. The pill dispenser will be packaged with pain medication (1 dispenser with vicodin, 1 with prescription ibuprofen, 1 with acetaminophen) that has been coencapsulated with ingestible event markers (IEMs, Proteus Discover).

Trial Locations (1)

08901

Rutgers Health University Dental Associates, New Brunswick

All Listed Sponsors
collaborator

iPill Dispenser

UNKNOWN

lead

Rutgers, The State University of New Jersey

OTHER

NCT04414917 - Reducing Opioid Use and Misuse After Wisdom Molar Extractions | Biotech Hunter | Biotech Hunter